A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes
about
Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'Multidrug-resistant tuberculosis in prison inmates, AzerbaijanTrends in mortality of tuberculosis patients in the United States: the long-term perspectiveTreatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysisClonal population of Mycobacterium tuberculosis strains reside within multiple lung cavitiesSelf-reported risks for multiple-drug resistance among new tuberculosis cases: implications for drug susceptibility screening and treatmentOutcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalenceA population-based cohort study of Mycobacterium tuberculosis Beijing strains: an emerging public health threat in an immigrant-receiving country?HIV and Tuberculosis: a Deadly Human SyndemicEvaluation and utilization as a public health tool of a national molecular epidemiological tuberculosis outbreak database within the United Kingdom from 1997 to 2001Use of interferon gamma-based assay to diagnose tuberculosis infection in health care workers after short term exposureMycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment.Multiple large clusters of tuberculosis in London: a cross-sectional analysis of molecular and spatial data.M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.Mycobacterium tuberculosis ecology in Venezuela: epidemiologic correlates of common spoligotypes and a large clonal cluster defined by MIRU-VNTR-24.First insights into the genetic diversity of Mycobacterium tuberculosis isolates from HIV-infected Mexican patients and mutations causing multidrug resistance.The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South AfricaTargeted hybridization of IS6110 fingerprints identifies the W-Beijing Mycobacterium tuberculosis strains among clinical isolates.How molecular epidemiology has changed what we know about tuberculosis.Evidence from molecular fingerprinting of limited spread of drug-resistant tuberculosis in TexasBacteriological and molecular analysis of rifampin-resistant Mycobacterium tuberculosis strains isolated in Australia.Genetic heterogeneity in Mycobacterium tuberculosis isolates reflected in IS6110 restriction fragment length polymorphism patterns as low-intensity bands.Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence communityEvaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital.Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997).Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery.Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho.Mycobacterium tuberculosis Beijing genotype, the Netherlands.Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam.Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates.The emergence of extensively drug-resistant tuberculosis (TB): TB/HIV coinfection, multidrug-resistant TB and the resulting public health threat from extensively drug-resistant TB, globally and in Canada.Discrimination of single-copy IS6110 DNA fingerprints of Mycobacterium tuberculosis isolates by high-resolution minisatellite-based typing.There is no correlation between sublineages and drug resistance of Mycobacterium tuberculosis Beijing/W lineage clinical isolates in Xinjiang, China.Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia.Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes.Molecular epidemiology of tuberculosis: current insights.Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.To control and beyond: moving towards eliminating the global tuberculosis threatSouthern East Asian origin and coexpansion of Mycobacterium tuberculosis Beijing family with Han Chinese.
P2860
Q27015848-0CFD0B3C-F28E-49B5-81B0-F43EDA3AD023Q28366613-DE4B7683-40FE-46EF-88C4-5D4494E26AE5Q28391525-52FABCB9-386B-4DB0-800F-ADB6F44B9FCBQ28476110-454AD9D8-6325-45B1-A79A-466B31DCEB9DQ28477078-E1D01274-0698-4063-A084-059B8AF626F9Q28477499-8BF25412-A7E5-482A-8DC6-3682309D7F5EQ28483868-3C181BBD-D228-49C9-9ABA-14AC2EE06AE0Q28484107-20D8D944-0B94-454C-B9BD-B250A674CC85Q30052157-C386649D-4BF7-4493-8E2E-97030E1B61E1Q30332824-85E2B6F5-5292-4831-A678-0B2651917F91Q30863509-ED2F4471-6674-4C49-AA25-78E006D1788EQ31032686-85F602DB-E17B-4477-9F81-219F82F6D756Q31158885-3AE1F995-3B84-4C41-AD45-95CB153FFE28Q33286329-D6E0F886-1632-4C61-A824-1B8878C9C4EDQ33491276-75DDE54D-C239-4C5F-8B9F-A921F009F4B3Q33541750-D89CC262-2EF9-46ED-A288-D0DF0101886DQ33756724-CF13C32E-22E8-4D12-80E2-3417FBDCD339Q33859179-6249C912-8758-4BEE-B6D1-5A5FA948E796Q33897688-01EB756D-35D6-4C4F-8B6D-FEBC962CD27AQ33962974-4B5C5AA6-3045-4C6F-832C-F46C530CE347Q33964071-12474A9A-4C32-49E0-872D-C462E8936753Q33970591-AE2E6D2F-7D7C-4263-9670-BBA0EC2217FEQ33971262-63519ECD-72C6-4ED0-9D13-41DE241648DAQ33971960-4CB4A524-61A9-4897-A622-CC0523E88E56Q33974563-3ADE1C9D-BB95-4BEB-ACCB-21365E28EE40Q33980394-B8C9E83D-5631-4F94-8553-C7F4946277CCQ34410451-116863FA-1C50-4203-A0C9-68D90AEEEAA7Q34463467-4D455C7D-4E0D-49A3-88C1-0FA0DE1E2462Q34548980-CB3055DB-EE48-4C61-A6F3-C2B7269E3595Q34555065-8E972F87-3998-4CD6-B1F3-DE2F1C55B6ECQ34680842-CCEBF4D3-B61B-4BC1-A676-DA14E66835D0Q34857567-7F3889B3-9998-44F2-849A-F0E1DA45AB6AQ34943381-81B34BE6-E64B-468A-B50B-8121349D6F56Q34992863-78A25EB8-C6B6-4151-AEC5-A3793BEF05EAQ35014534-FC2109D0-8C01-4FC7-9A87-AD3E61AB5BFEQ35033562-B97F1D1C-BA2D-40C4-AD40-0A97BE240C09Q35070843-910588DB-C010-4B7C-9F07-F6D36ACDD672Q35370503-FB788044-C6C0-4F5A-AA10-E01C0237B425Q35572043-708AF251-5CA2-4151-9421-658E9075217EQ35818616-3165AE30-9A0F-432F-A118-221D977D1B07
P2860
A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes
description
article publié dans la revue scientifique Journal of the American Medical Association
@fr
im Oktober 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Journal of the American Medical Association
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 1996
@uk
name
A multi-institutional outbreak ...... emiology and clinical outcomes
@en
A multi-institutional outbreak ...... emiology and clinical outcomes
@nl
type
label
A multi-institutional outbreak ...... emiology and clinical outcomes
@en
A multi-institutional outbreak ...... emiology and clinical outcomes
@nl
prefLabel
A multi-institutional outbreak ...... emiology and clinical outcomes
@en
A multi-institutional outbreak ...... emiology and clinical outcomes
@nl
P2093
P356
P1476
A multi-institutional outbreak ...... emiology and clinical outcomes
@en
P2093
B N Kreisworth
J T Crawford
L F Sherman
P I Fujiwara
T R Frieden
P304
P356
10.1001/JAMA.276.15.1229
P407
P577
1996-10-01T00:00:00Z